is mounjaro a tirzepatide FDA approves new version of diabetes drug to be sold for weight loss What is Mounjaro (Tirzepatide) and

Mounjaro (tirzepatide) is a prescription medication approved to treat type 2 diabetes that has also shown promise in terms of weight loss

You can inject it in the abdomen, thigh, or upper arm

FDA-approved options for chronic weight management include: Other GLP-1 receptor agonists (semaglutide, liraglutide) Combination therapies (phentermine-topiramate ER, naltrexone-bupropion ER) Orlistat Metformin for patients with diabetes or prediabetes, which provides modest weight-neutral or weight-loss effects Realistic expectations are essential

These steps are essential to managing and preventing semaglutide-induced rash, allowing you to continue your treatment with minimal skin issues

Appetite suppression is established and caloric deficit drives consistent loss